Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 154 No. 11 (2024)

Prediction of electroconvulsive therapy response and remission in late-life depression: a review

DOI
https://doi.org/10.57187/s.3684
Cite this as:
Swiss Med Wkly. 2024;154:3684
Published
05.11.2024

Summary

Electroconvulsive therapy is an effective and well-tolerated antidepressant treatment for the elderly population. The place of electroconvulsive therapy in the treatment sequence for depression in the elderly is currently not well established. This review aims to identify the factors that contribute to a positive response and remission in elderly patients with depression undergoing electroconvulsive therapy treatment.

We searched five bibliographic databases (Medline ALL Ovid, Embase.com, APA PsycInfo Ovid, Cochrane Library Wiley and Web of Science Core Collection) for articles published between 1995 and June 2023. Of the 2149 articles screened, 19 were included in the review.

No significant associations were found between remission and/or response and salivary cortisol, baseline hippocampal and white matter hyperintensities, total amyloid load or global cortical atrophy. The reviewed articles did not show a significant difference in remission between unilateral and bilateral electroconvulsive therapy treatment. Other interesting findings are that moderately elevated levels of CRP and S100B levels, lower retardation scores, poorer performance on the word reading task at baseline and longer post-ictal reorientation time may be associated with higher remission and/or response rates. Medial temporal atrophy can be associated with lower Montgomery-Åsberg Depression Rating Scale (MADRS) decrease after electroconvulsive therapy. Finally, elderly patients had higher rates of electroconvulsive therapy response; retardation and psychotic features may mediate this association.

Incorporation of this data into clinical practice may facilitate a personalised approach to electroconvulsive therapy. However, research on this topic is scarce and there are few studies that focus specifically on older people.

References

  1. Taylor WD. Clinical practice. Depression in the elderly. N Engl J Med. 2014 Sep;371(13):1228–36. doi: https://doi.org/10.1056/NEJMcp1402180 DOI: https://doi.org/10.1056/NEJMcp1402180
  2. Jackson JC, Pandharipande PP, Girard TD, Brummel NE, Thompson JL, Hughes CG, et al.; Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors (BRAIN-ICU) study investigators. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014 May;2(5):369–79. doi: https://doi.org/10.1016/S2213-2600(14)70051-7 DOI: https://doi.org/10.1016/S2213-2600(14)70051-7
  3. Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019 Aug;9(1):188. doi: https://doi.org/10.1038/s41398-019-0514-6 DOI: https://doi.org/10.1038/s41398-019-0514-6
  4. Rasmussen K. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (second edition). J ect. 2002;18(1):58-9. DOI: https://doi.org/10.1097/00124509-200203000-00015
  5. Geduldig ET, Kellner CH. Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression. Curr Psychiatry Rep. 2016 Apr;18(4):40. doi: https://doi.org/10.1007/s11920-016-0674-5 DOI: https://doi.org/10.1007/s11920-016-0674-5
  6. Slade EP, Jahn DR, Regenold WT, Case BG. Association of electroconvulsive therapy with psychiatric readmissions in US hospitals. JAMA Psychiatry. 2017 Aug;74(8):798–804. doi: https://doi.org/10.1001/jamapsychiatry.2017.1378 DOI: https://doi.org/10.1001/jamapsychiatry.2017.1378
  7. Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, et al.; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry. 2016 Sep;61(9):561–75. doi: https://doi.org/10.1177/0706743716660033 DOI: https://doi.org/10.1177/0706743716660033
  8. Association AP; American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000 Apr;157(4 Suppl):1–45.
  9. Spaans HP, Sienaert P, Bouckaert F, van den Berg JF, Verwijk E, Kho KH, et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry. 2015 Jan;206(1):67–71. doi: https://doi.org/10.1192/bjp.bp.114.148213 DOI: https://doi.org/10.1192/bjp.bp.114.148213
  10. Baba H, Kito S, Nukariya K, Takeshima M, Fujise N, Iga J, et al.; Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders. Psychiatry Clin Neurosci. 2022 Jun;76(6):222–34. doi: https://doi.org/10.1111/pcn.13349 DOI: https://doi.org/10.1111/pcn.13349
  11. Menon V, Varadharajan N, Faheem A, Andrade C. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2023 Jun;80(6):639–42. doi: https://doi.org/10.1001/jamapsychiatry.2023.0562 DOI: https://doi.org/10.1001/jamapsychiatry.2023.0562
  12. van Rooij SJ, Riva-Posse P, McDonald WM. The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression. Curr Treat Options Psychiatry. 2020 Sep;7(3):337–48. doi: https://doi.org/10.1007/s40501-020-00216-w DOI: https://doi.org/10.1007/s40501-020-00216-w
  13. Dominiak M, Antosik-Wójcińska AZ, Wojnar M, Mierzejewski P. Electroconvulsive Therapy and Age: Effectiveness, Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age. Pharmaceuticals (Basel). 2021 Jun;14(6):582. doi: https://doi.org/10.3390/ph14060582 DOI: https://doi.org/10.3390/ph14060582
  14. van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012 Jan;20(1):5–17. doi: https://doi.org/10.1097/JGP.0b013e31820dcbf9 DOI: https://doi.org/10.1097/JGP.0b013e31820dcbf9
  15. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010 Sep;68(6):568–77. doi: https://doi.org/10.1016/j.biopsych.2010.06.009 DOI: https://doi.org/10.1016/j.biopsych.2010.06.009
  16. Ninke T, Bayerl S, Groene P. [Anesthesia for electroconvulsive therapy]. Anaesthesist. 2021 Apr;70(4):271–9. doi: https://doi.org/10.1007/s00101-020-00831-5 DOI: https://doi.org/10.1007/s00101-020-00831-5
  17. Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015 Oct;76(10):1374–84. doi: https://doi.org/10.4088/JCP.14r09528 DOI: https://doi.org/10.4088/JCP.14r09528
  18. van Diermen L, van den Ameele S, Kamperman AM, Sabbe BC, Vermeulen T, Schrijvers D, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018 Feb;212(2):71–80. doi: https://doi.org/10.1192/bjp.2017.28 DOI: https://doi.org/10.1192/bjp.2017.28
  19. Suijk DL, Dols A, van Exel E, Stek ML, Veltman E, Bouckaert F, et al. Salivary cortisol as predictor for depression characteristics and remission in electroconvulsive therapy in older persons. World J Biol Psychiatry. 2019 Nov;20(9):683–90. doi: https://doi.org/10.1080/15622975.2018.1433326 DOI: https://doi.org/10.1080/15622975.2018.1433326
  20. Carlier A, Berkhof JG, Rozing M, Bouckaert F, Sienaert P, Eikelenboom P, et al. Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study.. J Affect Disord. 2019 Sep;256:509–16. doi: https://doi.org/10.1016/j.jad.2019.06.040 DOI: https://doi.org/10.1016/j.jad.2019.06.040
  21. Carlier A, Boers K, Veerhuis R, Bouckaert F, Sienaert P, Eikelenboom P, et al. S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy. Psychoneuroendocrinology. 2019 Dec;110:104414. doi: https://doi.org/10.1016/j.psyneuen.2019.104414 DOI: https://doi.org/10.1016/j.psyneuen.2019.104414
  22. Bouckaert F, Emsell L, Vansteelandt K, De Winter FL, Van den Stock J, Obbels J, et al. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes. J Affect Disord. 2019 May;251:114–20. doi: https://doi.org/10.1016/j.jad.2019.03.055 DOI: https://doi.org/10.1016/j.jad.2019.03.055
  23. Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, et al. White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. J Clin Psychiatry. 2011 Jan;72(1):104–12. doi: https://doi.org/10.4088/JCP.08m04989blu DOI: https://doi.org/10.4088/JCP.08m04989blu
  24. Tominaga K, Okazaki M, Higuchi H, Utagawa I, Nakamura E, Yamaguchi N. Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression. Int J Gen Med. 2011;4:515–9. doi: https://doi.org/10.2147/IJGM.S21029 DOI: https://doi.org/10.2147/IJGM.S21029
  25. Veltman EM, de Boer A, Dols A, van Exel E, Stek ML, Sienaert P, et al. Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life. J ECT. 2019 Dec;35(4):231–7. doi: https://doi.org/10.1097/YCT.0000000000000579 DOI: https://doi.org/10.1097/YCT.0000000000000579
  26. Bjølseth TM, Engedal K, Benth JŠ, Dybedal GS, Gaarden TL, Tanum L. Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depression. J Affect Disord. 2015 Oct;185:67–75. doi: https://doi.org/10.1016/j.jad.2015.06.021 DOI: https://doi.org/10.1016/j.jad.2015.06.021
  27. Magne Bjølseth T, Engedal K, Šaltytė Benth J, Bergsholm P, Strømnes Dybedal G, Lødøen Gaarden T, et al. Speed of recovery from disorientation may predict the treatment outcome of electroconvulsive therapy (ECT) in elderly patients with major depression. J Affect Disord. 2016 Jan;190:178–86. doi: https://doi.org/10.1016/j.jad.2015.10.013 DOI: https://doi.org/10.1016/j.jad.2015.10.013
  28. Stoppe A, Louzã M, Rosa M, Gil G, Rigonatti S. Fixed high-dose electroconvulsive therapy in the elderly with depression: a double-blind, randomized comparison of efficacy and tolerability between unilateral and bilateral electrode placement. J ECT. 2006 Jun;22(2):92–9. doi: https://doi.org/10.1097/00124509-200606000-00003 DOI: https://doi.org/10.1097/00124509-200606000-00003
  29. Dominiak M, Goetz Z, Antosik-Wojcinska AZ, Swiecicki L. Right unilateral versus bilateral formula-based electroconvulsive therapy in the treatment of major depression in elderly patients: a randomised, open label, pilot controlled trial. Psychogeriatrics. 2021 Mar;21(2):175–84. doi: https://doi.org/10.1111/psyg.12652 DOI: https://doi.org/10.1111/psyg.12652
  30. Bjølseth TM, Engedal K, Benth JŠ, Dybedal GS, Gaarden TL, Tanum L. Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trial. J Affect Disord. 2015 Apr;175:8–17. doi: https://doi.org/10.1016/j.jad.2014.12.054 DOI: https://doi.org/10.1016/j.jad.2014.12.054
  31. Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, et al.; CORE/PRIDE Work Group. Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Psychiatry. 2016 Nov;173(11):1101–9. doi: https://doi.org/10.1176/appi.ajp.2016.15081101 DOI: https://doi.org/10.1176/appi.ajp.2016.15081101
  32. Ward MJ, Karim HT, Jessen ZF, Ghuman AS, Richardson RM, Reynolds CF 3rd, et al. Association between increased theta cordance and early response to ECT in late-life depression. Int J Geriatr Psychiatry. 2020 Feb;35(2):147–52. doi: https://doi.org/10.1002/gps.5220 DOI: https://doi.org/10.1002/gps.5220
  33. Huuhka M, Korpisammal L, Haataja R, Leinonen E. One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants. J ECT. 2004 Sep;20(3):179–85. doi: https://doi.org/10.1097/00124509-200409000-00010 DOI: https://doi.org/10.1097/00124509-200409000-00010
  34. Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, et al.; CORE/PRIDE Work Group. A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study. Am J Psychiatry. 2016 Nov;173(11):1110–8. doi: https://doi.org/10.1176/appi.ajp.2016.16010118 DOI: https://doi.org/10.1176/appi.ajp.2016.16010118
  35. Wagenmakers MJ, Oudega ML, Klaus F, Wing D, Orav G, Han LK, et al. BrainAge of patients with severe late-life depression referred for electroconvulsive therapy. J Affect Disord. 2023 Jun;330:1–6. doi: https://doi.org/10.1016/j.jad.2023.02.047 DOI: https://doi.org/10.1016/j.jad.2023.02.047
  36. Heijnen WT, Kamperman AM, Tjokrodipo LD, Hoogendijk WJ, van den Broek WW, Birkenhager TK. Influence of age on ECT efficacy in depression and the mediating role of psychomotor retardation and psychotic features. J Psychiatr Res. 2019 Feb;109:41–7. doi: https://doi.org/10.1016/j.jpsychires.2018.11.014 DOI: https://doi.org/10.1016/j.jpsychires.2018.11.014
  37. Tew JD Jr, Mulsant BH, Haskett RF, Prudic J, Thase ME, Crowe RR, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999 Dec;156(12):1865–70. doi: https://doi.org/10.1176/ajp.156.12.1865 DOI: https://doi.org/10.1176/ajp.156.12.1865
  38. Suzuki A, Aoshima T, Fukasawa T, Yoshida K, Higuchi H, Shimizu T, et al. A three-factor model of the MADRS in major depressive disorder. Depress Anxiety. 2005;21(2):95–7. doi: https://doi.org/10.1002/da.20058 DOI: https://doi.org/10.1002/da.20058
  39. Parker G, Hadzi-Pavlovic D, Eyers K. Melancholia: a disorder of movement and mood: a phenomenological and neurobiological review. Cambridge University Press; 1996. doi: https://doi.org/10.1017/CBO9780511759024 DOI: https://doi.org/10.1017/CBO9780511759024
  40. Leuchter AF, Cook IA, Lufkin RB, Dunkin J, Newton TF, Cummings JL, et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage. 1994 Jun;1(3):208–19. doi: https://doi.org/10.1006/nimg.1994.1006 DOI: https://doi.org/10.1006/nimg.1994.1006
  41. Iosifescu DV. Electroencephalography-derived biomarkers of antidepressant response. Harv Rev Psychiatry. 2011;19(3):144–54. doi: https://doi.org/10.3109/10673229.2011.586549 DOI: https://doi.org/10.3109/10673229.2011.586549
  42. Cole JH, Franke K. Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers. Trends Neurosci. 2017 Dec;40(12):681–90. doi: https://doi.org/10.1016/j.tins.2017.10.001 DOI: https://doi.org/10.1016/j.tins.2017.10.001
  43. Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back. Front Psychiatry. 2020 Jan;10:974. doi: https://doi.org/10.3389/fpsyt.2019.00974 DOI: https://doi.org/10.3389/fpsyt.2019.00974
  44. Tural U, Irvin MK, Iosifescu DV. Correlation between S100B and severity of depression in MDD: A meta-analysis. World J Biol Psychiatry. 2022 Jul;23(6):456–63. doi: https://doi.org/10.1080/15622975.2021.2013042 DOI: https://doi.org/10.1080/15622975.2021.2013042
  45. de la Torre-Luque A, Ayuso-Mateos JL, Sanchez-Carro Y, de la Fuente J, Lopez-Garcia P. Inflammatory and metabolic disturbances are associated with more severe trajectories of late-life depression. Psychoneuroendocrinology. 2019 Dec;110:104443. doi: https://doi.org/10.1016/j.psyneuen.2019.104443 DOI: https://doi.org/10.1016/j.psyneuen.2019.104443
  46. Sawyer K, Corsentino E, Sachs-Ericsson N, Steffens DC. Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls. Aging Ment Health. 2012;16(6):753–62. doi: https://doi.org/10.1080/13607863.2012.678478 DOI: https://doi.org/10.1080/13607863.2012.678478
  47. Hsieh MH, McQuoid DR, Levy RM, Payne ME, MacFall JR, Steffens DC. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry. 2002 Jun;17(6):519–25. doi: https://doi.org/10.1002/gps.611 DOI: https://doi.org/10.1002/gps.611
  48. Kranaster L, Aksay SS, Bumb JM, Janke C, Alonso A, Hoyer C, et al. Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study. Eur Neuropsychopharmacol. 2016 Dec;26(12):1877–84. doi: https://doi.org/10.1016/j.euroneuro.2016.11.004 DOI: https://doi.org/10.1016/j.euroneuro.2016.11.004
  49. Mahgoub N, Alexopoulos GS. Amyloid hypothesis: is there a role for antiamyloid treatment in late-life depression? Am J Geriatr Psychiatry. 2016 Mar;24(3):239–47. doi: https://doi.org/10.1016/j.jagp.2015.12.003 DOI: https://doi.org/10.1016/j.jagp.2015.12.003
  50. Dominiak M, Antosik-Wójcińska AZ, Goetz Z, Sikorska O, Stefanowski B, Gorostiza D, et al. Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial. J Psychiatr Res. 2021 Jan;133:52–9. doi: https://doi.org/10.1016/j.jpsychires.2020.12.002 DOI: https://doi.org/10.1016/j.jpsychires.2020.12.002
  51. Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP, Nobler MS. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J ECT. 2000 Jun;16(2):110–20. doi: https://doi.org/10.1097/00124509-200006000-00003 DOI: https://doi.org/10.1097/00124509-200006000-00003
  52. Martin DM, Gálvez V, Loo CK. Predicting Retrograde Autobiographical Memory Changes Following Electroconvulsive Therapy: Relationships between Individual, Treatment, and Early Clinical Factors. Int J Neuropsychopharmacol. 2015 Jun;18(12):pyv067. doi: https://doi.org/10.1093/ijnp/pyv067 DOI: https://doi.org/10.1093/ijnp/pyv067
  53. Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S. Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry. 1992 Mar;160(3):355–9. doi: https://doi.org/10.1192/bjp.160.3.355 DOI: https://doi.org/10.1192/bjp.160.3.355
  54. Hickie I, Parsonage B, Parker G. Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depression. Br J Psychiatry. 1990 Jul;157(1):65–71. doi: https://doi.org/10.1192/bjp.157.1.65 DOI: https://doi.org/10.1192/bjp.157.1.65